kneat.com (TSE:KSI) Sets New 1-Year High – What’s Next?

kneat.com, inc. (TSE:KSI) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$6.65 and last traded at C$6.65, with a volume of 40992 shares trading hands. The stock had previously closed at C$6.35.

Analyst Ratings Changes

A number of research firms have weighed in on KSI. Cibc World Mkts upgraded kneat.com to a “strong-buy” rating in a report on Tuesday, October 29th. CIBC set a C$6.00 price target on kneat.com and gave the stock an “outperform” rating in a research note on Tuesday, October 29th.

kneat.com Stock Up 3.8 %

The company’s 50-day moving average price is C$5.92 and its 200 day moving average price is C$5.13. The company has a debt-to-equity ratio of 95.14, a quick ratio of 1.50 and a current ratio of 1.47. The stock has a market cap of C$566.74 million, a PE ratio of -41.19, a price-to-earnings-growth ratio of 597.67 and a beta of 1.08.

kneat.com (TSE:KSI) last posted its quarterly earnings data on Wednesday, November 6th. The company reported C$0.01 EPS for the quarter, topping the consensus estimate of C($0.05) by C$0.06. kneat.com had a negative return on equity of 51.13% and a negative net margin of 31.19%. During the same period last year, the business posted ($0.05) earnings per share. As a group, analysts forecast that kneat.com, inc. will post -0.12 EPS for the current fiscal year.

About kneat.com

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.